According to the Company, intravenous administration of the affected product could lead to “site specific infections as well as serious systemic infections which may be life-threatening.” SterRx, LLC ...

Exela Pharma Sciences is recalling an additional 14 lots of Sodium Bicarbonate Injection, USP, 8.4%, 50mEq/50 mL vial, 20-count carton. In total, the Company is recalling 63 lots of the product due to ...

SterRx, LLC today announced the voluntary nationwide recall of three lots of Sodium Bicarbonate in 5% Dextrose Injection 150mEq per 1,000 mL due to waterborne microbial contamination. SterRx, LLC has ...

Long Grove Pharmaceuticals is set to introduce Sodium Bicarbonate Injection. The product is commonly used in critical care settings yet routinely found on the drug shortages list, the company said.

Lenoir, North Carolina. Exela Pharma Sciences, LLC, (Exela) is expanding their recall, adding fourteen (14) lots to the ongoing voluntary recall of forty-nine (49) lots of Sodium Bicarbonate Injection ...

ELMWOOD PARK, N.J., Nov. 4, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce the upcoming launch1 of 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq ...

December 29, 2010 — A voluntary recall has been issued for 39 lots of American Regent's sodium bicarbonate injection because of the presence of particulate matter, the US Food and Drug Administration ...

Hospira, Inc., a Pfizer company, is voluntarily recalling the lots listed in the table below of 4.2% Sodium Bicarbonate Injection, USP ABBOJECT® Glass Syringe, 5 mEq/10 mL; 8.4% Sodium Bicarbonate ...

CHARLOTTE, N.C.--(BUSINESS WIRE)-- Premier Inc. (NASDAQ: PINC), through its ProvideGx™ program, has partnered with Exela Pharma Sciences, LLC, to supply sodium bicarbonate injection to healthcare ...

Jan. 4, 2006 — The US Food and Drug Administration (FDA) approved in November 2005 first-time generic formulations of promethazine HCl 12.5-, 25-, and 50-mg tablets for approved indications in ...